NOvartis LONG 112 & 100 Target 140NOvartis LONG Weekly Demand 112
NOvartis LONG Weekly Demand 100
NOvartis Strong Momentum Yearly & QTRLY
Advance Price action Demand 112 & 100
Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
7.637 CHF
13.34 B CHF
40.83 B CHF
1.75 B
About NOVARTIS N
Sector
CEO
Vasant Narasimhan
Headquarters
Basel
Website
Founded
1996
ISIN
CH0012005267
FIGI
BBG008B4YSV8
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
NVS Novartis AG Options Ahead of EarningsAnalyzing the options chain and the chart patterns of NVS Novartis AG prior to the earnings report this week,
I would consider purchasing the 110usd strike price Calls with
an expiration date of 2024-8-16,
for a premium of approximately $3.30.
If these options prove to be profitable prior to the ear
Novartis Strikes $1.01 Bln Deal with Arvinas for Prostate DrugsNovartis ( NYSE:NVS ), the Swiss pharmaceutical giant, has made a strategic move in the field of cancer treatment by securing a licensing agreement with Arvinas, a U.S. biotech company. The deal, valued at up to $1.01 billion, grants Novartis access to Arvinas' experimental prostate cancer drug, ARV
Investment Opportunity Novartis AG (short)Wyckoff in Daily/Weekly timeframe, we can observe the price took the upside liquidity (bc) before breaking the structure downside.
I'm expecting the price to go back on my grey zone (supply) around 99 before continuing the bearish trend.
First target 88 (sc)
Second target 83 (demand zone)
I will l
NOVARTIS: Bearish- Wolfe Wave + ROC DivergenceNOVARTIS: Bearish- Wolfe Wave + ROC Divergence
Monitor the EMA.50 and 200
According to Ichimoku, Kijun around 87.87
Watch out for the GAP around 79
NVS SHORT OPPORTUNITYLarge market players are selling the stock pre-market at or around 99.50. It could be a signal for a stock to decline. Technical analysis and the volume support the idea.
Longing Novartis (NVS) Longing Novartis (NVS): A Strategic Investment Amidst Geopolitical Tensions
This article presents a compelling rationale for considering a long position in Novartis (NVS) stock. The primary driving factor behind this investment strategy is Novartis' close association with Sandoz (SDZ) following the
$NVS with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for NYSE:NVS after a positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 60%.
$NVS with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for NYSE:NVS after a positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 50%.
Free Guide:Top 3 Stocks To Buy Right Now
--
This strategy is very good for beginners
--
In today's video, we attacked how to short using this
very same strategy
--
Also, we look at its weak points when using it for shorting
--
Watching this video you will know the
Top 3 Stocks To Buy Right Now
--
But hurry! because by next week 1
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where NOT is featured.
Frequently Asked Questions
The current price of NOT is 91.237 CHF — it has decreased by −0.17% in the past 24 hours. Watch NOVARTIS AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange NOVARTIS AG stocks are traded under the ticker NOT.
NOT stock has fallen by −1.59% compared to the previous week, the month change is a −10.09% fall, over the last year NOVARTIS AG has showed a 6.13% increase.
We've gathered analysts' opinions on NOVARTIS AG future price: according to them, NOT price has a max estimate of 121.46 CHF and a min estimate of 84.90 CHF. Watch NOT chart and read a more detailed NOVARTIS AG stock forecast: see what analysts think of NOVARTIS AG and suggest that you do with its stocks.
NOT stock is 1.00% volatile and has beta coefficient of 0.82. Track NOVARTIS AG stock price on the chart and check out the list of the most volatile stocks — is NOVARTIS AG there?
Today NOVARTIS AG has the market capitalization of 178.02 B, it has decreased by −1.88% over the last week.
Yes, you can track NOVARTIS AG financials in yearly and quarterly reports right on TradingView.
NOVARTIS AG is going to release the next earnings report on Jan 31, 2025. Keep track of upcoming events with our Earnings Calendar.
NOT earnings for the last quarter are 1.75 CHF per share, whereas the estimation was 1.64 CHF resulting in a 6.27% surprise. The estimated earnings for the next quarter are 1.64 CHF per share. See more details about NOVARTIS AG earnings.
NOVARTIS AG revenue for the last quarter amounts to 10.87 B CHF, despite the estimated figure of 10.84 B CHF. In the next quarter, revenue is expected to reach 11.48 B CHF.
NOT net income for the last quarter is 2.76 B CHF, while the quarter before that showed 2.94 B CHF of net income which accounts for −5.89% change. Track more NOVARTIS AG financial stats to get the full picture.
Yes, NOT dividends are paid annually. The last dividend per share was 3.30 CHF. As of today, Dividend Yield (TTM)% is 3.63%. Tracking NOVARTIS AG dividends might help you take more informed decisions.
NOVARTIS AG dividend yield was 3.89% in 2023, and payout ratio reached 51.36%. The year before the numbers were 3.83% and 105.08% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has 76.06 K employees. See our rating of the largest employees — is NOVARTIS AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NOVARTIS AG EBITDA is 18.02 B CHF, and current EBITDA margin is 44.33%. See more stats in NOVARTIS AG financial statements.
Like other stocks, NOT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NOVARTIS AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NOVARTIS AG technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NOVARTIS AG stock shows the sell signal. See more of NOVARTIS AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.